These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 22876562

  • 1. Marked increase of final height by long-term aromatase inhibition in a boy with idiopathic short stature.
    Krebs A, Moske-Eick O, Doerfer J, Roemer-Pergher C, van der Werf-Grohmann N, Schwab KO.
    J Pediatr Endocrinol Metab; 2012; 25(5-6):581-5. PubMed ID: 22876562
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial.
    Hero M, Norjavaara E, Dunkel L.
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6396-402. PubMed ID: 16189252
    [Abstract] [Full Text] [Related]

  • 3. Letrozole vs anastrozole for height augmentation in short pubertal males: first year data.
    Neely EK, Kumar RB, Payne SL, Ranadive SA, Suchet DI.
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4086-93. PubMed ID: 25137428
    [Abstract] [Full Text] [Related]

  • 4. Randomized Trial of Aromatase Inhibitors, Growth Hormone, or Combination in Pubertal Boys with Idiopathic, Short Stature.
    Mauras N, Ross JL, Gagliardi P, Yu YM, Hossain J, Permuy J, Damaso L, Merinbaum D, Singh RJ, Gaete X, Mericq V.
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4984-4993. PubMed ID: 27710241
    [Abstract] [Full Text] [Related]

  • 5. Outcome analysis of aromatase inhibitor therapy to increase adult height in males with predicted short adult stature and/or rapid pubertal progress: a retrospective chart review.
    Shams K, Cameo T, Fennoy I, Hassoun AA, Lerner SE, Aranoff GS, Sopher AB, Yang C, McMahon DJ, Oberfield SE.
    J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):725-30. PubMed ID: 24756052
    [Abstract] [Full Text] [Related]

  • 6. Combined treatment with GH and anastrozole in a pubertal boy with Cushing's disease and postsurgical GH deficiency.
    Boronat M, Marrero D, López-Plasencia Y, Nóvoa Y, García-Delgado Y, Nóvoa FJ.
    Eur J Endocrinol; 2012 Jun; 166(6):1101-5. PubMed ID: 22447814
    [Abstract] [Full Text] [Related]

  • 7. A double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature.
    Salehpour S, Alipour P, Razzaghy-Azar M, Ardeshirpour L, Shamshiri A, Monfared MF, Gharib A.
    Horm Res Paediatr; 2010 Jun; 74(6):428-35. PubMed ID: 20628237
    [Abstract] [Full Text] [Related]

  • 8. Impact of aromatase inhibitor therapy on bone turnover, cortical bone growth and vertebral morphology in pre- and peripubertal boys with idiopathic short stature.
    Hero M, Mäkitie O, Kröger H, Nousiainen E, Toiviainen-Salo S, Dunkel L.
    Horm Res; 2009 Jun; 71(5):290-7. PubMed ID: 19339794
    [Abstract] [Full Text] [Related]

  • 9. Letrozole as a booster therapy in growth hormone deficiency.
    Kumar KV, Jayaraman M, Verma A, Modi KD.
    Indian Pediatr; 2009 Jul; 46(7):625-7. PubMed ID: 19638662
    [Abstract] [Full Text] [Related]

  • 10. Adding Letrozole to Growth Hormone and Gonadotropin-Releasing Hormone Analog Increases Height in Girls With Short Stature: A Hospital Record-Based Retrospective Study.
    Li C, Wang X, Nie M, Mao J, Wu X.
    Endocr Pract; 2024 Jul; 30(7):639-646. PubMed ID: 38723894
    [Abstract] [Full Text] [Related]

  • 11. Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty.
    Hero M, Wickman S, Dunkel L.
    Clin Endocrinol (Oxf); 2006 May; 64(5):510-3. PubMed ID: 16649968
    [Abstract] [Full Text] [Related]

  • 12. Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years.
    Mauras N, Gonzalez de Pijem L, Hsiang HY, Desrosiers P, Rapaport R, Schwartz ID, Klein KO, Singh RJ, Miyamoto A, Bishop K.
    J Clin Endocrinol Metab; 2008 Mar; 93(3):823-31. PubMed ID: 18165285
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aromatase inhibitors for short stature in male children and adolescents.
    McGrath N, O'Grady MJ.
    Cochrane Database Syst Rev; 2015 Oct 08; 2015(10):CD010888. PubMed ID: 26447646
    [Abstract] [Full Text] [Related]

  • 17. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W, Briody J, Moore B, Lu PW, Cowell CT.
    Bone; 2005 Nov 08; 37(5):642-50. PubMed ID: 16139578
    [Abstract] [Full Text] [Related]

  • 18. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
    Wit JM, Boersma B, de Muinck Keizer-Schrama SM, Nienhuis HE, Oostdijk W, Otten BJ, Delemarre-Van de Waal HA, Reeser M, Waelkens JJ, Rikken B.
    Clin Endocrinol (Oxf); 1995 Apr 08; 42(4):365-72. PubMed ID: 7750190
    [Abstract] [Full Text] [Related]

  • 19. Use of aromatase inhibitors in children with short stature.
    Cernich J, Jacobson JD, Moore WV, Popovic J.
    Pediatr Endocrinol Rev; 2004 Sep 08; 2(1):2-7. PubMed ID: 16429098
    [Abstract] [Full Text] [Related]

  • 20. Vertebral morphology in aromatase inhibitor-treated males with idiopathic short stature or constitutional delay of puberty.
    Hero M, Toiviainen-Salo S, Wickman S, Mäkitie O, Dunkel L.
    J Bone Miner Res; 2010 Jul 08; 25(7):1536-43. PubMed ID: 20200972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.